|
1000 | 61351 | Bp33 | Blood pressure QTL 33 | | 0.0018 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 1 | 27716890 | Rat | n/a | region | qtl |
1000 | 1641905 | Colcr1 | Colorectal carcinoma resistance QTL 1 | 4.3 | 0.0003 | intestine integrity trait (VT:0010554) | benign colorectal tumor surface area measurement (CMO:0001799) | 4 | 1 | 29494328 | Rat | n/a | region | qtl |
1000 | 61415 | Eae11 | Experimental allergic encephalomyelitis QTL 11 | 2.9 | | nervous system integrity trait (VT:0010566) | post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422) | 4 | 1 | 39505420 | Rat | n/a | region | qtl |
1000 | 61333 | Gluco16 | Glucose level QTL 16 | 4.3 | 0.00001 | adipocyte glucose uptake trait (VT:0004185) | absolute change in adipocyte glucose uptake (CMO:0000873) | 4 | 1 | 30372989 | Rat | n/a | region | qtl |
1000 | 1357343 | Gluco4 | Glucose level QTL 4 | | 0.00002 | adipocyte glucose uptake trait (VT:0004185) | adipocyte maximal glucose uptake to basal glucose uptake ratio (CMO:0000874) | 4 | 1 | 33250345 | Rat | n/a | region | qtl |
1000 | 1357341 | Gluco5 | Glucose level QTL 5 | 6.4 | | adipocyte free fatty acid secretion trait (VT:0010465) | absolute change in adipocyte free fatty acid secretion per unit volume (CMO:0001446) | 4 | 1 | 33250345 | Rat | n/a | region | qtl |
1000 | 738021 | Hcar13 | Hepatocarcinoma resistance QTL 13 | 4.3 | | liver integrity trait (VT:0010547) | liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464) | 4 | 1 | 32584199 | Rat | n/a | region | qtl |
1000 | 8552903 | Pigfal2 | Plasma insulin-like growth factor 1 level QTL 2 | 7.3 | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 4 | 1 | 31934116 | Rat | n/a | region | qtl |
1000 | 724557 | Plsm1 | Polydactyly-luxate syndrome (PLS) morphotypes QTL 1 | | 0.0003 | forelimb integrity trait (VT:0010562) | front foot phalanges count (CMO:0001947) | 4 | 1 | 27716890 | Rat | n/a | region | qtl |
1000 | 9589046 | Scfw2 | Subcutaneous fat weight QTL 2 | 5.54 | 0.001 | subcutaneous adipose mass (VT:1000472) | abdominal subcutaneous fat pad weight (CMO:0002069) | 4 | 1 | 31934116 | Rat | n/a | region | qtl |
1000 | 61408 | Scl23 | Serum cholesterol level QTL 23 | | 0.0005 | blood HDL phospholipid amount (VT:0010504) | serum high density lipoprotein phospholipid level (CMO:0001567) | 4 | 1 | 27716890 | Rat | n/a | region | qtl |
1000 | 9590100 | Sffal4 | Serum free fatty acids level QTL 4 | 7.36 | 0.05 | blood free fatty acid amount (VT:0001553) | plasma free fatty acids level (CMO:0000546) | 4 | 1 | 31934116 | Rat | n/a | region | qtl |
1000 | 9589097 | Slep11 | Serum leptin concentration QTL 11 | 5.09 | 0.001 | blood leptin amount (VT:0005667) | plasma leptin level (CMO:0000781) | 4 | 1 | 31934116 | Rat | n/a | region | qtl |
1000 | 634323 | Hc2 | Hypercalciuria QTL 2 | 2.15 | | urine calcium amount (VT:0002985) | urine calcium excretion rate (CMO:0000763) | 4 | 210796 | 45210796 | Rat | n/a | region | qtl |
1000 | 2303168 | Bp330 | Blood pressure QTL 330 | 4.25 | 0.017 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 5214602 | 146446691 | Rat | n/a | region | qtl |
1000 | 619616 | Bp79 | Blood pressure QTL 79 | | 0.0292 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 5214602 | 78882945 | Rat | n/a | region | qtl |
1000 | 1358203 | Stl19 | Serum triglyceride level QTL 19 | 2.8 | 0.002 | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5218294 | 65958103 | Rat | n/a | region | qtl |
1000 | 2302371 | Stl22 | Serum triglyceride level QTL 22 | 5.15 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5218294 | 57114705 | Rat | n/a | region | qtl |
1000 | 1358201 | Gluco12 | Glucose level QTL12 | 1.6 | | adipocyte glucose uptake trait (VT:0004185) | adipocyte maximal glucose uptake (CMO:0000870) | 4 | 5218392 | 29593287 | Rat | n/a | region | qtl |
1000 | 631642 | Stl2 | Serum triglyceride level QTL 2 | 3.3 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5219178 | 56647776 | Rat | n/a | region | qtl |
1000 | 631209 | Bw2 | Body weight QTL2 | 4.2 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 4 | 9940885 | 44463908 | Rat | n/a | region | qtl |
1000 | 1300141 | Bp178 | Blood pressure QTL 178 | | | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 10024901 | 39524530 | Rat | n/a | region | qtl |
1000 | 6478724 | Anxrr35 | Anxiety related response QTL 35 | | 0.00449 | defecation behavior trait (VT:0010462) | defecation measurement (CMO:0000997) | 4 | 10084089 | 55084089 | Rat | n/a | region | qtl |
1000 | 6478766 | Anxrr47 | Anxiety related response QTL 47 | | 0.09637 | locomotor behavior trait (VT:0001392) | number of entries into a discrete space in an experimental apparatus (CMO:0000960) | 4 | 10084089 | 55084089 | Rat | n/a | region | qtl |
1000 | 6478769 | Anxrr48 | Anxiety related response QTL 48 | | 0.02514 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 4 | 10084089 | 55084089 | Rat | n/a | region | qtl |
1000 | 8694374 | Bw155 | Body weight QTL 155 | 3.39 | 0.001 | body lean mass (VT:0010483) | lean tissue morphological measurement (CMO:0002184) | 4 | 10084089 | 55084089 | Rat | n/a | region | qtl |
1000 | 8552906 | Pigfal3 | Plasma insulin-like growth factor 1 level QTL 3 | | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 4 | 10084089 | 55084089 | Rat | n/a | region | qtl |
1000 | 9590304 | Scort17 | Serum corticosterone level QTL 17 | 4.96 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 4 | 10084089 | 55084089 | Rat | n/a | region | qtl |
1000 | 631261 | Tcas3 | Tongue tumor susceptibility QTL 3 | 6.88 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 4 | 10814170 | 91360527 | Rat | n/a | region | qtl |
1000 | 2316958 | Gluco58 | Glucose level QTL 58 | 10 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 4 | 11320076 | 180699135 | Rat | n/a | region | qtl |
1000 | 2303585 | Bw86 | Body weight QTL 86 | 4 | | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 14678065 | 59678065 | Rat | n/a | region | qtl |
1000 | 2313401 | Anxrr27 | Anxiety related response QTL 27 | | | aggression-related behavior trait (VT:0015014) | tameness/aggressiveness composite score (CMO:0002136) | 4 | 17933508 | 62933508 | Rat | n/a | region | qtl |
1000 | 70222 | Eae2 | Experimental allergic encephalomyelitis QTL 2 | 4.3 | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) | 4 | 21333343 | 39505420 | Rat | n/a | region | qtl |
1000 | 61412 | Pia2 | Pristane induced arthritis QTL 2 | 3.9 | | joint integrity trait (VT:0010548) | post-insult time to onset of experimental arthritis (CMO:0001450) | 4 | 21333343 | 62278020 | Rat | n/a | region | qtl |
1000 | 1354665 | Stl10 | Serum triglyceride level QTL 10 | 3.57 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 21333343 | 44463908 | Rat | n/a | region | qtl |
1000 | 8552803 | Bw144 | Body weight QTL 144 | 16 | | body mass (VT:0001259) | change in body weight to body weight ratio (CMO:0002216) | 4 | 22710685 | 34430484 | Rat | n/a | region | qtl |
1000 | 6909122 | Insul22 | Insulin level QTL 22 | 4.63 | | blood insulin amount (VT:0001560) | plasma insulin level (CMO:0000342) | 4 | 26907285 | 75585128 | Rat | n/a | region | qtl |
1000 | 6909128 | Pancm4 | Pancreatic morphology QTL 4 | 11.35 | | pancreas mass (VT:0010144) | pancreas wet weight (CMO:0000626) | 4 | 26907285 | 75585128 | Rat | n/a | region | qtl |
1000 | 8655906 | Rf60 | Renal function QTL 60 | 3.8 | | blood creatinine amount (VT:0005328) | creatinine clearance (CMO:0000765) | 4 | 29494195 | 81006281 | Rat | n/a | region | qtl |
1000 | 12798520 | Anxrr55 | Anxiety related response QTL 55 | 4.45 | 0.01 | locomotor behavior trait (VT:0001392) | number of rearing movements with lid-pushing in an experimental apparatus (CMO:0002715) | 4 | 32583980 | 114627242 | Rat | n/a | region | qtl |
1000 | 11530004 | Niddm71 | Non-insulin dependent diabetes mellitus QTL 71 | | 0.001 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 4 | 32584199 | 52754138 | Rat | n/a | region | qtl |
1000 | 8655949 | Rf62 | Renal function QTL 62 | 22 | | blood urea nitrogen amount (VT:0005265) | plasma urea nitrogen level (CMO:0000586) | 4 | 34430119 | 44463908 | Rat | n/a | region | qtl |
1000 | 8552801 | Bw143 | Body weight QTL 143 | 7.3 | | body mass (VT:0001259) | change in body weight to body weight ratio (CMO:0002216) | 4 | 34430484 | 82490359 | Rat | n/a | region | qtl |
1000 | 8552782 | Vie1 | Viral induced encephalitis QTL 1 | 26.4 | | brain integrity trait (VT:0010579) | encephalitis incidence/prevalence measurement (CMO:0002361) | 4 | 34430484 | 82490359 | Rat | n/a | region | qtl |
1000 | 8552809 | Vie5 | Viral induced encephalitis QTL 5 | 25.3 | | brain integrity trait (VT:0010579) | encephalitis incidence/prevalence measurement (CMO:0002361) | 4 | 34430484 | 82490359 | Rat | n/a | region | qtl |
1000 | 8655961 | Kidm43 | Kidney mass QTL 43 | 18 | | kidney mass (VT:0002707) | both kidneys wet weight (CMO:0000085) | 4 | 36303261 | 103194984 | Rat | n/a | region | qtl |
1000 | 2290374 | Gluco32 | Glucose level QTL 32 | 6.27 | | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 4 | 37177950 | 44463908 | Rat | n/a | region | qtl |
1000 | 4889511 | Gluco61 | Glucose level QTL 61 | 4.7 | 0.001 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 4 | 37177950 | 40869000 | Rat | n/a | region | qtl |
1000 | 1300156 | Bp179 | Blood pressure QTL 179 | 2.85 | | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 38465774 | 39524530 | Rat | n/a | region | qtl |
1000 | 1358352 | Srcrt3 | Stress Responsive Cort QTL 3 | 2.29 | | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 4 | 38465774 | 146803430 | Rat | n/a | region | qtl |
1000 | 61475 | Aia2 | Adjuvant induced arthritis QTL 2 | 5.8 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 4 | 39505275 | 73892441 | Rat | n/a | region | qtl |
1000 | 1300139 | Hrtrt6 | Heart rate QTL 6 | 2.85 | | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 4 | 39524264 | 116179656 | Rat | n/a | region | qtl |
1000 | 1331807 | Rf31 | Renal function QTL 31 | 2.988 | | urine potassium amount (VT:0010539) | urine potassium level (CMO:0000128) | 4 | 39524264 | 74726312 | Rat | n/a | region | qtl |
1000 | 61445 | Strs3 | Sensitivity to stroke QTL 3 | 3 | | cerebrum integrity trait (VT:0010549) | post-insult time to onset of cerebrovascular lesion (CMO:0002343) | 4 | 40433388 | 85433388 | Rat | n/a | region | qtl |
1000 | 8694439 | Bw168 | Body weight QTL 168 | 9.57 | 0.001 | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 4 | 40433414 | 85433414 | Rat | n/a | region | qtl |
1000 | 6893678 | Bw108 | Body weight QTL 108 | 2.6 | 0.006 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 43457976 | 88457976 | Rat | n/a | region | qtl |
1000 | 1576305 | Emca6 | Estrogen-induced mammary cancer QTL 6 | 5.8 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 4 | 44463720 | 155883716 | Rat | n/a | region | qtl |
1000 | 1354612 | Foco1 | Food consumption QTL 1 | 8.87 | | eating behavior trait (VT:0001431) | food intake rate (CMO:0000427) | 4 | 44463908 | 148090542 | Rat | n/a | region | qtl |
1000 | 1354660 | Salc1 | Saline consumption QTL 1 | 11.26 | | drinking behavior trait (VT:0001422) | saline drink intake rate (CMO:0001627) | 4 | 44463908 | 148090542 | Rat | n/a | region | qtl |
1000 | 2312567 | Glom19 | Glomerulus QTL 19 | 1.9 | 0.006 | kidney glomerulus morphology trait (VT:0005325) | index of glomerular damage (CMO:0001135) | 4 | 45456990 | 146803430 | Rat | n/a | region | qtl |
1000 | 10450818 | Scl76 | Serum cholesterol level QTL 76 | 3.6 | 0.01 | blood VLDL cholesterol amount (VT:0005144) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 49178116 | 57114705 | Rat | n/a | region | qtl |
1000 | 10450821 | Scl77 | Serum cholesterol level QTL 77 | 4.1 | 0.01 | blood VLDL cholesterol amount (VT:0005144) | blood high density lipoprotein cholesterol level (CMO:0000052) | 4 | 49178116 | 57114705 | Rat | n/a | region | qtl |
1000 | 10450825 | Scl78 | Serum cholesterol level QTL 78 | 3.7 | 0.01 | blood VLDL cholesterol amount (VT:0005144) | blood low density lipoprotein cholesterol level (CMO:0000053) | 4 | 49178116 | 57114705 | Rat | n/a | region | qtl |
1000 | 1298082 | Stresp4 | Stress response QTL 4 | | | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 4 | 50119848 | 146803430 | Rat | n/a | region | qtl |
1000 | 5685009 | Bmd86 | Bone mineral density QTL 86 | 3.7 | | tibia mineral mass (VT:1000283) | bone mineral density (CMO:0001226) | 4 | 56647776 | 78882945 | Rat | n/a | region | qtl |
1000 | 5685012 | Bmd87 | Bone mineral density QTL 87 | 5.1 | | tibia mineral mass (VT:1000283) | bone mineral content (CMO:0001554) | 4 | 56647776 | 78882945 | Rat | n/a | region | qtl |
1000 | 4889969 | Bss96 | Bone structure and strength QTL 96 | 4.9 | | tibia size trait (VT:0100001) | tibia cortical bone volume (CMO:0001725) | 4 | 56647776 | 78882945 | Rat | n/a | region | qtl |
1000 | 4889972 | Bss97 | Bone structure and strength QTL 97 | 5.6 | | tibia size trait (VT:0100001) | tibia total bone volume (CMO:0001724) | 4 | 56647776 | 78882945 | Rat | n/a | region | qtl |
1000 | 70200 | Alc18 | Alcohol consumption QTL 18 | 9.2 | | drinking behavior trait (VT:0001422) | ethanol intake volume to total fluid intake volume ratio (CMO:0001591) | 4 | 56647873 | 149491524 | Rat | n/a | region | qtl |
1000 | 1641833 | Alc21 | Alcohol consumption QTL 21 | 8.6 | 0.0001 | drinking behavior trait (VT:0001422) | ethanol drink intake rate (CMO:0001407) | 4 | 56698790 | 126192555 | Rat | n/a | region | qtl |
1000 | 631546 | Bp86 | Blood pressure QTL 86 | 3.2 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 57114432 | 91360801 | Rat | n/a | region | qtl |
1000 | 634311 | Sach7 | Saccharin preference QTL 7 | | | taste sensitivity trait (VT:0001986) | saccharin intake volume to total fluid intake volume ratio (CMO:0001601) | 4 | 57114432 | 81266970 | Rat | n/a | region | qtl |
1000 | 61336 | Bp21 | Blood pressure QTL 21 | 4.6 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 57114705 | 78881294 | Rat | n/a | region | qtl |
1000 | 1358363 | Sradr3 | Stress Responsive Adrenal Weight QTL 3 | 6.19 | | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 4 | 57486946 | 102486946 | Rat | n/a | region | qtl |
1000 | 1558651 | Swd3 | Spike wave discharge measurement QTL 3 | 4.62 | 0.000024 | brain electrophysiology trait (VT:0010557) | brain spike-and-wave discharge frequency (CMO:0001742) | 4 | 58432133 | 92991462 | Rat | n/a | region | qtl |
1000 | 631671 | Iddm11 | Insulin dependent diabetes mellitus QTL 11 | 3.6 | 0.0012 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 4 | 58635877 | 78886137 | Rat | n/a | region | qtl |
1000 | 738031 | Alc14 | Alcohol consumption QTL 14 | 7.6 | 0.00003 | consumption behavior trait (VT:0002069) | ethanol drink intake rate to body weight ratio (CMO:0001616) | 4 | 59948935 | 154902892 | Rat | n/a | region | qtl |
1000 | 738016 | Alc16 | Alcohol consumption QTL 16 | 3.6 | 0.00015 | consumption behavior trait (VT:0002069) | ethanol drink intake rate to body weight ratio (CMO:0001616) | 4 | 59948935 | 154902892 | Rat | n/a | region | qtl |
1000 | 738009 | Sach4 | Saccharine consumption QTL 4 | 4.9 | 0.000016 | consumption behavior trait (VT:0002069) | saccharin intake volume to total fluid intake volume ratio (CMO:0001601) | 4 | 59948935 | 154902892 | Rat | n/a | region | qtl |
1000 | 1578657 | Bss12 | Bone structure and strength QTL 12 | 8.9 | | femur morphology trait (VT:0000559) | femoral neck cross-sectional area (CMO:0001697) | 4 | 60220938 | 105220938 | Rat | n/a | region | qtl |
1000 | 1578658 | Bss13 | Bone structure and strength QTL 13 | 8 | | femur strength trait (VT:0010010) | femoral neck polar moment of inertia (CMO:0001670) | 4 | 60220938 | 105220938 | Rat | n/a | region | qtl |
1000 | 2300179 | Bmd50 | Bone mineral density QTL 50 | 5.9 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 4 | 60928534 | 105928534 | Rat | n/a | region | qtl |
1000 | 1549839 | Bw52 | Body weight QTL 52 | | 0.0001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 4 | 61697658 | 115089733 | Rat | n/a | region | qtl |
1000 | 1549843 | Bw53 | Body weight QTL 53 | | 0.0001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 4 | 61697658 | 103194791 | Rat | n/a | region | qtl |
1000 | 61418 | Pia5 | Pristane induced arthritis QTL 5 | 4.5 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 4 | 62277855 | 128289560 | Rat | n/a | region | qtl |
1000 | 6478684 | Anxrr30 | Anxiety related response QTL 30 | | 0.00087 | defecation behavior trait (VT:0010462) | defecation rate (CMO:0000998) | 4 | 62753847 | 107753847 | Rat | n/a | region | qtl |
1000 | 6478743 | Anxrr40 | Anxiety related response QTL 40 | | 0.83076 | defecation behavior trait (VT:0010462) | defecation rate (CMO:0000998) | 4 | 62753847 | 107753847 | Rat | n/a | region | qtl |
1000 | 6478772 | Anxrr49 | Anxiety related response QTL 49 | | 0.15488 | defecation behavior trait (VT:0010462) | defecation rate (CMO:0000998) | 4 | 62753847 | 107753847 | Rat | n/a | region | qtl |
1000 | 631651 | Bp124 | Blood pressure QTL 124 | 3 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 62879517 | 107879517 | Rat | n/a | region | qtl |
1000 | 7394826 | Bw126 | Body weight QTL 126 | | 0.002 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 4 | 62933269 | 87483707 | Rat | n/a | region | qtl |
1000 | 70192 | BpQTLcluster5 | Blood pressure QTL cluster 5 | 4.183 | | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 4 | 62933508 | 114921294 | Rat | n/a | region | qtl |
1000 | 70192 | BpQTLcluster5 | Blood pressure QTL cluster 5 | 4.183 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 62933508 | 114921294 | Rat | n/a | region | qtl |
1000 | 70192 | BpQTLcluster5 | Blood pressure QTL cluster 5 | 4.183 | | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 62933508 | 114921294 | Rat | n/a | region | qtl |
1000 | 70192 | BpQTLcluster5 | Blood pressure QTL cluster 5 | 4.183 | | arterial blood pressure trait (VT:2000000) | percent change in mean arterial blood pressure (CMO:0002035) | 4 | 62933508 | 114921294 | Rat | n/a | region | qtl |
1000 | 70192 | BpQTLcluster5 | Blood pressure QTL cluster 5 | 4.183 | | arterial blood pressure trait (VT:2000000) | percent change in systolic blood pressure (CMO:0000747) | 4 | 62933508 | 114921294 | Rat | n/a | region | qtl |
1000 | 70192 | BpQTLcluster5 | Blood pressure QTL cluster 5 | 4.183 | | arterial blood pressure trait (VT:2000000) | absolute change in pulse pressure (CMO:0001882) | 4 | 62933508 | 114921294 | Rat | n/a | region | qtl |
1000 | 70192 | BpQTLcluster5 | Blood pressure QTL cluster 5 | 4.183 | | arterial blood pressure trait (VT:2000000) | absolute change in mean arterial blood pressure (CMO:0000533) | 4 | 62933508 | 114921294 | Rat | n/a | region | qtl |
1000 | 8552807 | Vie4 | Viral induced encephalitis QTL 4 | 7.3 | | brain integrity trait (VT:0010579) | encephalitis incidence/prevalence measurement (CMO:0002361) | 4 | 62933508 | 82490359 | Rat | n/a | region | qtl |
1000 | 631674 | Iddm14 | Insulin dependent diabetes mellitus QTL 14 | | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 4 | 64528739 | 157573521 | Rat | n/a | region | qtl |
1000 | 2312569 | Pur19 | Proteinuria QTL 19 | 3.4 | 0.001 | urine total protein amount (VT:0000032) | urine total protein excretion rate (CMO:0000756) | 4 | 65882107 | 96130297 | Rat | n/a | region | qtl |
1000 | 2317577 | Eae24 | Experimental allergic encephalomyelitis QTL 24 | | | nervous system integrity trait (VT:0010566) | post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422) | 4 | 66993185 | 72752834 | Rat | n/a | region | qtl |
1000 | 2317577 | Eae24 | Experimental allergic encephalomyelitis QTL 24 | | | nervous system integrity trait (VT:0010566) | percentage of study population developing experimental autoimmune encephalomyelitis during a period of time (CMO:0001047) | 4 | 66993185 | 72752834 | Rat | n/a | region | qtl |
1000 | 2317577 | Eae24 | Experimental allergic encephalomyelitis QTL 24 | | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis severity score (CMO:0001419) | 4 | 66993185 | 72752834 | Rat | n/a | region | qtl |
1000 | 2306547 | Iddm38 | Insulin dependent diabetes mellitus QTL 38 | | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 4 | 67386669 | 70362197 | Rat | n/a | region | qtl |
1000 | 61330 | Eau1 | Experimental allergic uveoretinitis QTL 1 | | 0.0003 | uvea integrity trait (VT:0010551) | experimental autoimmune uveitis score (CMO:0001504) | 4 | 70362013 | 132642728 | Rat | n/a | region | qtl |
1000 | 634344 | Hcar7 | Hepatocarcinoma resistance QTL 7 | 7.8 | | liver integrity trait (VT:0010547) | liver tumorous lesion area to total liver area ratio (CMO:0001075) | 4 | 70808386 | 115808386 | Rat | n/a | region | qtl |
1000 | 634344 | Hcar7 | Hepatocarcinoma resistance QTL 7 | 7.8 | | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 4 | 70808386 | 115808386 | Rat | n/a | region | qtl |
1000 | 631646 | Stl4 | Serum triglyceride level QTL 4 | 6.5 | 0.0001 | blood triglyceride amount (VT:0002644) | plasma triglyceride level (CMO:0000548) | 4 | 73169846 | 132642728 | Rat | n/a | region | qtl |
1000 | 724522 | Bp146 | Blood pressure QTL 146 | 2.2 | 0.0021 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 73630210 | 118630210 | Rat | n/a | region | qtl |
1000 | 2302051 | Pia28 | Pristane induced arthritis QTL 28 | 5.3 | 0.001 | blood autoantibody amount (VT:0003725) | serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112) | 4 | 73630210 | 118630210 | Rat | n/a | region | qtl |
1000 | 70167 | Bw22 | Body weight QTL 22 | 3.1 | | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 76647384 | 117676292 | Rat | n/a | region | qtl |
1000 | 1357342 | Bw40 | Body weight QTL 40 | | 0.001 | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 76647384 | 117676292 | Rat | n/a | region | qtl |
1000 | 2306545 | Iddm39 | Insulin dependent diabetes mellitus QTL 39 | | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 4 | 77356721 | 77687411 | Rat | n/a | region | qtl |
1000 | 631662 | Hcar2 | Hepatocarcinoma resistance QTL 2 | 3.1 | 0.0003 | liver integrity trait (VT:0010547) | volume of individual liver tumorous lesion (CMO:0001078) | 4 | 78878504 | 123878504 | Rat | n/a | region | qtl |
1000 | 631556 | Bp135 | Blood pressure QTL 135 | | 0.017 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 78881294 | 117676292 | Rat | n/a | region | qtl |
1000 | 2317586 | Eae25 | Experimental allergic encephalomyelitis QTL 25 | 9.300000190734863 | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis severity score (CMO:0001419) | 4 | 78882817 | 83007655 | Rat | n/a | region | qtl |
1000 | 2317586 | Eae25 | Experimental allergic encephalomyelitis QTL 25 | 9.300000190734863 | | nervous system integrity trait (VT:0010566) | percentage of study population developing experimental autoimmune encephalomyelitis during a period of time (CMO:0001047) | 4 | 78882817 | 83007655 | Rat | n/a | region | qtl |
1000 | 2317586 | Eae25 | Experimental allergic encephalomyelitis QTL 25 | 9.300000190734863 | | nervous system integrity trait (VT:0010566) | post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422) | 4 | 78882817 | 83007655 | Rat | n/a | region | qtl |
1000 | 2317586 | Eae25 | Experimental allergic encephalomyelitis QTL 25 | 9.300000190734863 | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis duration (CMO:0001424) | 4 | 78882817 | 83007655 | Rat | n/a | region | qtl |
1000 | 61364 | Iddm2 | Insulin dependent diabetes mellitus QTL 2 | | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 4 | 78885890 | 102684881 | Rat | n/a | region | qtl |
1000 | 738015 | Pia9 | Pristane induced arthritis QTL 9 | 4.5 | 0.048 | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 4 | 80694870 | 125694870 | Rat | n/a | region | qtl |
1000 | 2306899 | Bp338 | Blood pressure QTL 338 | | 0.071 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 81006124 | 120102625 | Rat | n/a | region | qtl |
1000 | 1641919 | Alc22 | Alcohol consumption QTL 22 | | 0.0005 | drinking behavior trait (VT:0001422) | ethanol drink intake rate (CMO:0001407) | 4 | 81192555 | 126192555 | Rat | n/a | region | qtl |
1000 | 70177 | Xhs1 | X-ray hypersensitivity QTL 1 | 25.1 | | intestine integrity trait (VT:0010554) | post-insult time to onset of moribundity (CMO:0001896) | 4 | 82798864 | 152731274 | Rat | n/a | region | qtl |
1000 | 2306794 | Ean2 | Experimental allergic neuritis QTL 2 | 6.4 | | nervous system integrity trait (VT:0010566) | IFNG-secreting splenocyte count (CMO:0002122) | 4 | 83428419 | 95853334 | Rat | n/a | region | qtl |
1000 | 1576316 | Ept5 | Estrogen-induced pituitary tumorigenesis QTL 5 | 3.8 | | pituitary gland mass (VT:0010496) | pituitary gland wet weight (CMO:0000853) | 4 | 83428419 | 177635233 | Rat | n/a | region | qtl |
1000 | 634334 | Xhs3 | X-ray hypersensitivity QTL 3 | 10 | | intestine integrity trait (VT:0010554) | post-insult time to onset of moribundity (CMO:0001896) | 4 | 84728680 | 129854654 | Rat | n/a | region | qtl |
1000 | 12798523 | Anxrr56 | Anxiety related response QTL 56 | 2.83 | 0.05 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 4 | 85253748 | 150276390 | Rat | n/a | region | qtl |
1000 | 1582232 | Gluco25 | Glucose level QTL 25 | 3.6 | 0.0023 | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 4 | 85253748 | 148090731 | Rat | n/a | region | qtl |
1000 | 1358202 | Gluco11 | Glucose level QTL 11 | 2.4 | 0.02 | adipocyte glucose uptake trait (VT:0004185) | absolute change in adipocyte glucose uptake (CMO:0000873) | 4 | 85379421 | 167139601 | Rat | n/a | region | qtl |
1000 | 61476 | Aia3 | Adjuvant induced arthritis QTL 3 | 3.9 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 4 | 86730991 | 131730991 | Rat | n/a | region | qtl |
1000 | 1578670 | Bss14 | Bone structure and strength QTL 14 | 16.4 | | femur morphology trait (VT:0000559) | bone trabecular cross-sectional area (CMO:0002311) | 4 | 87327165 | 132327165 | Rat | n/a | region | qtl |
1000 | 1578662 | Bss15 | Bone structure and strength QTL 15 | 19.6 | | femur width (VT:1000666) | femoral neck width (CMO:0001695) | 4 | 87327165 | 132327165 | Rat | n/a | region | qtl |
1000 | 2317587 | Eae26 | Experimental allergic encephalomyelitis QTL 26 | | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis severity score (CMO:0001419) | 4 | 88656681 | 103194984 | Rat | n/a | region | qtl |
1000 | 1578655 | Bmd11 | Bone mineral density QTL 11 | 11 | | femur mineral mass (VT:0010011) | total volumetric bone mineral density (CMO:0001728) | 4 | 90850165 | 135850165 | Rat | n/a | region | qtl |